Lab Personnel

Dr. Bradford Berges Bradford Berges Principal Investigator
Ph.D., Cell and Molecular Biology, University of Pennsylvania, 2005
B.S., Microbiology, Brigham Young University, 1999
From: Philadelphia, Pennsylvania
The main goal of our research is to better understand diseases associated with AIDS so that we can develop new ways to prevent and/or treat those diseases.  In particular, we are focused on AIDS-associated diseases that are caused by other viral infections.
Anne Tanner Anne Tanner Graduate Student
Pursuing a M.S. in Microbiology
B.S., Microbiology, Brigham Young University, 2008
From: Salt Lake City, Utah
I am attempting to make a Rag2 -/- gammachain -/- humanized mouse as a novel model to study human herpesvirus 6A tropism and infection.
Kyle Jensen
Kyle Jensen Graduate Student
Pursuing a M.S. in Microbiology
From: Brigham City, UT
Working to isolate & characterize bacteriophage that kill MRSA
Art Lee Art Lee Undergraduate Student
Major: B.S., Medical Lab Science
From: Phoenixville, PA
Developing vaccine against Dengue infections
Mark Murdock
Mark Murdock Undergraduate Student
Major: B.S., Genetics & Biotechnology
From: Provo, UT
I find and characterize bacteriophage that can be used for making a new MRSA treatment
Gregory Low
Gregory Low Undergraduate Student
Major: B.S., Microbiology
From: Philadelphia, PA
I do research on LANA's role in KSHV persistence
Heon (Jake) J. Jung
Heon (Jake) J. Jung Undergraduate Student
Major: B.S., Microbiology
From: South Korea
HIV-2 infection in humanized mice (RAG-hu)
Jacob Hatch
Jacob Hatch Undergraduate Student
Major: B.S., Physiology & Developmental Biology
From: Provo, UT
MRSA research
Sterling Adams
Sterling Adams Undergraduate Student
Major: B.S., Zoology
From: Sandy, UT
I work on HIV-1 evolution through recombination in humanized mice. This provides a better look at HIV replication mechanisms in vivo
Hillary Willyerd Hillary Willyerd Undergraduate Student
Major: B.S., Molecular Biology
From: St. Louis, MO
I'm working with HIV-2 infected humanized mice and using quantitative PCR to analyze the disease's progression and comparing it to HIV-1